Ex-10.2 Amendment to Stockholders Agreement
EX-10.2 2 b75905ctexv10w2.htm EX-10.2 AMENDMENT TO STOCKHOLDERS AGREEMENT exv10w2
Exhibit 10.2
AMENDMENT TO STOCKHOLDERS AGREEMENT
This AMENDMENT TO STOCKHOLDERS AGREEMENT, dated as of June 26, 2009 (this Amendment), is by and among CHIESI FARMACEUTICI SPA, a corporation organized under the laws of Italy, CRAIG A. COLLARD, CORNERSTONE BIOPHARMA HOLDINGS, LTD., a limited liability company organized under the laws of Anguilla, CAROLINA PHARMACEUTICALS LTD., a limited liability company organized under the laws of Bermuda, LUTZ FAMILY LIMITED PARTNERSHIP, North Carolina limited partnership, STEVEN M. LUTZ and CORNERSTONE THERAPEUTICS INC., a Delaware corporation (the Company).
RECITALS
WHEREAS, the parties entered into a Stockholders Agreement, dated as of May 6, 2009 (the Stockholders Agreement); and
WHEREAS, the parties desire to amend the Stockholders Agreement in certain respects.
NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:
1. Annex A to the Stockholders Agreement is hereby deleted in its entirety and replaced with the Annex A attached hereto.
2. This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
[Remainder of this page is intentionally left blank.]
IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.
CORNERSTONE THERAPEUTICS INC. | ||||
By: | /s/ David Price | |||
Name: | David Price | |||
Title: | Chief Financial Officer | |||
CHIESI FARMACEUTICI SPA | ||||
By: | /s/ Alberto Chiesi | |||
Name: | Alberto Chiesi | |||
Title: | President | |||
[Signature Page to Amendment to Stockholders Agreement]
/s/ Craig A. Collard | ||||
Craig A. Collard | ||||
CORNERSTONE BIOPHARMA HOLDINGS, LTD. | ||||
By: | /s/ Craig A. Collard | |||
Name: | Craig A. Collard | |||
Title: | CEO | |||
CAROLINA PHARMACEUTICALS LTD. | ||||
By: | /s/ Craig A. Collard | |||
Name: | Craig A. Collard | |||
Title: | CEO | |||
[Signature Page to Amendment to Stockholders Agreement]
/s/ Steven M. Lutz | ||||
Steven M. Lutz | ||||
LUTZ FAMILY LIMITED PARTNERSHIP | ||||
By: | STEVEN M. LUTZ, its general partner | |||
/s/ Steven M. Lutz | ||||
Steven M. Lutz | ||||
[Signature Page to Amendment to Stockholders Agreement]
ANNEX A
COVERED SHARES
COVERED SHARES
Number of Covered | ||||
Stockholder | Shares | |||
Craig A. Collard | 228,559 | |||
Cornerstone Biopharma Holdings, Ltd. | 1,561,780 | |||
Carolina Pharmaceuticals Ltd. | 947,207 | |||
Lutz Family Limited Partnership | 261,878 | |||
Steven M. Lutz | 195,227 |